Clinical Trial Update: Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients

View source ↗

Summary

A clinical trial comparing growth factor-enriched plasma to autologous serum for healing corneal cells in patients with aniridia; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aniridia

Drugs mentioned

• Autologous Serum
• Growth Factor-enriched Plasma

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Aniridia | Status: RECRUITING